Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

Company Overview

Big Cypress Acquisition Corp. is a special purpose acquisition company, or SPAC, incorporated in Delaware to pursue one or more business combination opportunities with private operating businesses. The firm does not currently conduct any commercial operations of its own.

The company trades on the OTC Markets under the symbol BCYP. Proceeds from its initial public offering are held in a trust account and are available for consummating a qualifying business combination or for return to shareholders should the SPAC not complete a transaction within the time frame set by its governing documents.

Big Cypress Acquisition’s business model leverages the SPAC structure to provide private companies with an alternative route to public markets. Any proposed merger or acquisition requires shareholder approval and regulatory review before the combined entity may commence operations.

Key Stats

• Today's Range: $8.21 to $12.90
• 50-Day Range: $8.44 to $8.44
• 52-Week Range: $8.21 to $12.90
• Volume: 15.34 million shs
• Average Volume: 160,982 shs
• Market Capitalization: $124.84 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BCYP Stock Analysis - Frequently Asked Questions

How have BCYP shares performed this year?

Big Cypress Acquisition's stock was trading at $8.44 at the start of the year. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44.

How were Big Cypress Acquisition's earnings last quarter?

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) posted its quarterly earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million.

How do I buy shares of Big Cypress Acquisition?

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Big Cypress Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Big Cypress Acquisition investors own include FuelCell Energy (FCEL), Onconova Therapeutics (ONTX), Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT) and Adamis Pharmaceuticals (ADMP).

Company Calendar

• Last Earnings: 11/11/2014
• Today: 9/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biological Products, Except Diagnostic
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:BCYP
• CIK: 1399587
• Web: www.bluecalypso.com
• Phone: 305-204-3338
• Fax: N/A
• Employees: 17
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.13
• Quick Ratio: 6.13

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 14,792,000
• Free Float: N/A
• Market Cap: $124.84 million
• Optionable: Not Optionable
• Beta: N/A